DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/8j9sv7/mergers_and) has announced the addition of the "Mergers and Acquisitions in the IVD Market" report to their offering.
In the IVD industry, the goal is to build better tests and stronger companies. The future of the industry lies in the development of more sensitive, faster, user-friendly, IT-capable devices for a host of new protein and molecular markers. No company, big or small, owns all of the technology needed to develop these new tests and systems. They have to get the pieces they do not have from acquisitions and partnerships.
IVD Mergers and Acquisitions shows how dynamic the IVD industry currently is, recording and examining some 130 significant acquisitions that have taken place from 2012 to early 2015. And this is likely only a small portion of what is really happening in the market; more deals are still to come. Overall, uncertainty in reimbursement and healthcare reform in Europe and the U.S. have changed the acquisition landscape. Some deals allow larger companies to acquire new technologies and enter new segments, but still others are distinct moves meant to set up toeholds in India, China, South Korea and other emerging countries.
As an industry, the goal is to move beyond interoperability challenges and refocus energy on advancing healthcare. Next steps include the creation of the coming generation of IVD products, which will integrate the clinical lab into the mainstream of healthcare information flow.
Key Topics Covered:
ONE: EXECUTIVE SUMMARY
TWO: IVD MERGERS AND ACQUISITIONS
- Major Developments
- Thermo Fisher
- Becton Dickinson (BD)
- EKF Diagnostics
- Ortho Clinical Diagnostics
- Trends in Selected Segments
- Next Generation Sequencing Segment
- Tissue and Cell Diagnostics Segment
- Companion Diagnostics Segment
- Acquisitions That Played a Role in Product Development
For more information visit http://www.researchandmarkets.com/research/8j9sv7/mergers_and